Jaahnavi Dave

Jaahnavi Dave is a PhD student based in Ottawa, Ontario. She works in the cancer immunotherapy program at the Ottawa Hospital Research Institute in the lab of John Bell.¹⁾

In January-May 2018, Dave worked as a research intern at the Goodman Cancer Research Centre at McGill University.

As an undergraduate student at McGill University, Dave participated in BioCanRx's 2018 Summer Studentship Program. She worked in the laboratory of Denis Claude Roy at the Université de Montréal and Hôpital Maisonneuve-Rosemont.²⁾ She conducted research on targeted cell therapy funded by BioCanRx.³⁾

Dave won the first place prize for best oral presentation at the 2019 Ontario-Quebec Undergraduate Immunology Conference.⁴⁾ Starting in May 2019, she participated in a summer internship with the National Research Council Canada in the Human Health Therapeutics department.⁵⁾

In May 2021, Dave co-signed an open letter to Prime Minister Justin Trudeau calling on him to issue a temporary waiver on Canada's intellectual property rights on COVID-19 vaccines and to provide them to the World Health Organization's COVID-19 Technology Access Pool (C-TAP).⁶⁾ During this same period, Dave was communicating by e-mail as part of the Public Health Agency of Canada (PHAC)'s COVID-19 Therapeutics Team.⁷⁾

Dave has published research funded by a Fonds de Recherche de Québec - Santé Schan Ontario Graduate Scholarship.⁸⁾

She also published a paper funded by Mitacs, Ottawa Hospital Foundation, the Thistledown Foundation, the Terry Fox Research Institute, and the Canadian Cancer Society on TOH-Vac1, a COVID-19 vaccine candidate based on the original smallpox vaccine.⁹⁾

• ResearchGate